FARALLON CAPITAL MANAGEMENT, L.L.C. Diversified Active

Location: San Francisco, CA

CIK: 0000909661 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value: $11.65B

Holdings (102)

— ALLERGAN PLC 14.1%
Value $1.647B Shares 9,300,000 Share Price $177.10 Est. Cost/Share — Unrealized @ Report Date —
SPY SPDR S&P 500 ETF TR 6.2%
Value $722M Shares 2,616,500 Share Price $275.75 Est. Cost/Share — Unrealized @ Report Date —
FIS FIDELITY NATL INFORMATION SV 4.8%
Value $562M Shares 4,621,208 Share Price $121.64 Est. Cost/Share — Unrealized @ Report Date —
CNC CENTENE CORP DEL 3.7%
Value $431M Shares 7,250,000 Share Price $59.41 Est. Cost/Share — Unrealized @ Report Date —
IQV IQVIA HLDGS INC 3.5%
Value $403M Shares 3,739,696 Share Price $107.86 Est. Cost/Share — Unrealized @ Report Date —
TMO THERMO FISHER SCIENTIFIC INC 3.0%
Value $353M Shares 1,243,215 Share Price $283.60 Est. Cost/Share — Unrealized @ Report Date —
GOOG ALPHABET INC 2.9%
Value $343M Shares 295,173 Share Price $1162.81 Est. Cost/Share — Unrealized @ Report Date —
CHTR CHARTER COMMUNICATIONS INC N 2.7%
Value $316M Shares 723,328 Share Price $436.31 Est. Cost/Share — Unrealized @ Report Date —
— IAC INTERACTIVECORP 2.6%
Value $307M Shares 1,715,000 Share Price $179.23 Est. Cost/Share — Unrealized @ Report Date —
ABBV ABBVIE INC 2.6%
Value $305M Shares 4,000,000 Share Price $76.19 Est. Cost/Share — Unrealized @ Report Date —
WAB WABTEC 2.6%
Value $304M Shares 6,322,354 Share Price $48.13 Est. Cost/Share — Unrealized @ Report Date —
— IHS MARKIT LTD 2.5%
Value $296M Shares 4,925,538 Share Price $60.00 Est. Cost/Share — Unrealized @ Report Date —
MSFT MICROSOFT CORP 2.5%
Value $288M Shares 1,823,720 Share Price $157.71 Est. Cost/Share — Unrealized @ Report Date —
V VISA INC 2.4%
Value $284M Shares 1,763,268 Share Price $161.12 Est. Cost/Share — Unrealized @ Report Date —
ELV ANTHEM INC 2.4%
Value $284M Shares 1,250,000 Share Price $227.04 Est. Cost/Share — Unrealized @ Report Date —
GD GENERAL DYNAMICS CORP 2.4%
Value $276M Shares 2,083,681 Share Price $132.31 Est. Cost/Share — Unrealized @ Report Date —
SHW SHERWIN WILLIAMS CO 2.0%
Value $234M Shares 509,130 Share Price $459.52 Est. Cost/Share — Unrealized @ Report Date —
CRM SALESFORCE COM INC 2.0%
Value $232M Shares 1,614,488 Share Price $143.98 Est. Cost/Share — Unrealized @ Report Date —
CI CIGNA CORP NEW 1.9%
Value $221M Shares 1,250,000 Share Price $177.18 Est. Cost/Share — Unrealized @ Report Date —
BABA ALIBABA GROUP HLDG LTD 1.9%
Value $218M Shares 1,123,500 Share Price $194.48 Est. Cost/Share — Unrealized @ Report Date —
— ACCELERON PHARMA INC 1.7%
Value $195M Shares 2,175,000 Share Price $89.87 Est. Cost/Share — Unrealized @ Report Date —
META FACEBOOK INC 1.6%
Value $181M Shares 1,087,524 Share Price $166.80 Est. Cost/Share — Unrealized @ Report Date —
EQIX EQUINIX INC 1.5%
Value $176M Shares 281,933 Share Price $624.57 Est. Cost/Share — Unrealized @ Report Date —
EXEL EXELIXIS INC 1.5%
Value $172M Shares 10,000,000 Share Price $17.22 Est. Cost/Share — Unrealized @ Report Date —
IOVA IOVANCE BIOTHERAPEUTICS INC 1.5%
Value $172M Shares 5,750,000 Share Price $29.93 Est. Cost/Share — Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 1.4%
Value $163M Shares 1,500,000 Share Price $108.85 Est. Cost/Share — Unrealized @ Report Date —
PANW PALO ALTO NETWORKS INC 1.4%
Value $162M Shares 986,721 Share Price $163.96 Est. Cost/Share — Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 1.3%
Value $155M Shares 1,376,349 Share Price $112.61 Est. Cost/Share — Unrealized @ Report Date —
TRU TRANSUNION 1.1%
Value $134M Shares 2,023,887 Share Price $66.18 Est. Cost/Share — Unrealized @ Report Date —
— BRISTOL-MYERS SQUIBB CO 1.1%
Value $134M Shares 35,200,000 Share Price $3.80 Est. Cost/Share — Unrealized @ Report Date —
— QIAGEN NV 1.1%
Value $123M Shares 2,960,986 Share Price $41.60 Est. Cost/Share — Unrealized @ Report Date —
— FORTY SEVEN INC 0.9%
Value $105M Shares 1,105,000 Share Price $95.42 Est. Cost/Share — Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 0.8%
Value $90M Shares 1,750,000 Share Price $51.43 Est. Cost/Share — Unrealized @ Report Date —
— RA PHARMACEUTICALS INC 0.6%
Value $69.13M Shares 1,440,000 Share Price $48.01 Est. Cost/Share — Unrealized @ Report Date —
FATE FATE THERAPEUTICS INC 0.6%
Value $66.63M Shares 3,000,000 Share Price $22.21 Est. Cost/Share — Unrealized @ Report Date —
— WRIGHT MED GROUP N V 0.6%
Value $65.18M Shares 2,275,000 Share Price $28.65 Est. Cost/Share — Unrealized @ Report Date —
GRFS GRIFOLS S A 0.5%
Value $62.7M Shares 3,113,222 Share Price $20.14 Est. Cost/Share — Unrealized @ Report Date —
— ZYMEWORKS INC 0.5%
Value $62.07M Shares 1,750,000 Share Price $35.47 Est. Cost/Share — Unrealized @ Report Date —
— ZOGENIX INC 0.5%
Value $55.64M Shares 2,250,000 Share Price $24.73 Est. Cost/Share — Unrealized @ Report Date —
— FIBROGEN INC 0.5%
Value $55.59M Shares 1,599,667 Share Price $34.75 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.5%
Value $53.92M Shares 7,170,213 Share Price $7.52 Est. Cost/Share — Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 0.5%
Value $53.58M Shares 2,000,000 Share Price $26.79 Est. Cost/Share — Unrealized @ Report Date —
— PLAYA HOTELS & RESORTS NV 0.5%
Value $53.56M Shares 30,606,930 Share Price $1.75 Est. Cost/Share — Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 0.4%
Value $49.46M Shares 35,102,000 Share Price $1.41 Est. Cost/Share — Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 0.4%
Value $46.12M Shares 600,000 Share Price $76.87 Est. Cost/Share — Unrealized @ Report Date —
EFX EQUIFAX INC 0.4%
Value $45.19M Shares 378,275 Share Price $119.45 Est. Cost/Share — Unrealized @ Report Date —
AGIO AGIOS PHARMACEUTICALS INC 0.4%
Value $44.35M Shares 1,250,000 Share Price $35.48 Est. Cost/Share — Unrealized @ Report Date —
— PTC THERAPEUTICS INC 0.4%
Value $42.58M Shares 39,676,000 Share Price $1.07 Est. Cost/Share — Unrealized @ Report Date —
— DECIPHERA PHARMACEUTICALS IN 0.4%
Value $41.17M Shares 1,000,000 Share Price $41.17 Est. Cost/Share — Unrealized @ Report Date —
— KARUNA THERAPEUTICS INC 0.4%
Value $40.83M Shares 567,047 Share Price $72.00 Est. Cost/Share — Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP DEL 0.3%
Value $34.61M Shares 365,000 Share Price $94.82 Est. Cost/Share — Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 0.3%
Value $34.24M Shares 350,000 Share Price $97.82 Est. Cost/Share — Unrealized @ Report Date —
VCYT VERACYTE INC 0.3%
Value $33.43M Shares 1,375,000 Share Price $24.31 Est. Cost/Share — Unrealized @ Report Date —
— PROGENICS PHARMACEUTICALS IN 0.3%
Value $31.35M Shares 8,250,000 Share Price $3.80 Est. Cost/Share — Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 0.3%
Value $30.67M Shares 49,172,000 Share Price $0.62 Est. Cost/Share — Unrealized @ Report Date —
— CARA THERAPEUTICS INC 0.3%
Value $30.38M Shares 2,300,000 Share Price $13.21 Est. Cost/Share — Unrealized @ Report Date —
ARWR ARROWHEAD PHARMACEUTICALS IN 0.2%
Value $28.77M Shares 1,000,000 Share Price $28.77 Est. Cost/Share — Unrealized @ Report Date —
— FORESCOUT TECHNOLOGIES INC 0.2%
Value $27.64M Shares 875,000 Share Price $31.59 Est. Cost/Share — Unrealized @ Report Date —
— AVROBIO INC 0.2%
Value $26.84M Shares 1,725,000 Share Price $15.56 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.2%
Value $26.71M Shares 2,054,486 Share Price $13.00 Est. Cost/Share — Unrealized @ Report Date —
— ZEALAND PHARMA A S 0.2%
Value $25.88M Shares 750,000 Share Price $34.50 Est. Cost/Share — Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 0.2%
Value $25.64M Shares 1,335,000 Share Price $19.21 Est. Cost/Share — Unrealized @ Report Date —
— INVITAE CORP 0.2%
Value $25.64M Shares 1,875,300 Share Price $13.67 Est. Cost/Share — Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 0.2%
Value $22.92M Shares 842,683 Share Price $27.20 Est. Cost/Share — Unrealized @ Report Date —
— PRINCIPIA BIOPHARMA INC 0.2%
Value $22.84M Shares 384,674 Share Price $59.38 Est. Cost/Share — Unrealized @ Report Date —
— INTERCEPT PHARMACEUTICALS IN 0.2%
Value $22.5M Shares 25,500,000 Share Price $0.88 Est. Cost/Share — Unrealized @ Report Date —
— TRICIDA INC 0.2%
Value $22M Shares 1,000,000 Share Price $22.00 Est. Cost/Share — Unrealized @ Report Date —
— MYOKARDIA INC 0.2%
Value $20.16M Shares 430,000 Share Price $46.88 Est. Cost/Share — Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 0.2%
Value $19.39M Shares 675,000 Share Price $28.72 Est. Cost/Share — Unrealized @ Report Date —
BX BLACKSTONE GROUP INC 0.2%
Value $18.36M Shares 402,811 Share Price $45.57 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.2%
Value $17.98M Shares 2,391,536 Share Price $7.52 Est. Cost/Share — Unrealized @ Report Date —
— THERAVANCE BIOPHARMA INC 0.1%
Value $15.69M Shares 16,360,000 Share Price $0.96 Est. Cost/Share — Unrealized @ Report Date —
CRSP CRISPR THERAPEUTICS AG 0.1%
Value $14.84M Shares 350,000 Share Price $42.41 Est. Cost/Share — Unrealized @ Report Date —
— AMARIN CORP PLC 0.1%
Value $14.5M Shares 3,625,000 Share Price $4.00 Est. Cost/Share — Unrealized @ Report Date —
— ATARA BIOTHERAPEUTICS INC 0.1%
Value $12.77M Shares 1,500,000 Share Price $8.51 Est. Cost/Share — Unrealized @ Report Date —
QURE UNIQURE NV 0.1%
Value $11.86M Shares 250,000 Share Price $47.45 Est. Cost/Share — Unrealized @ Report Date —
— STEMLINE THERAPEUTICS INC 0.1%
Value $11.37M Shares 2,350,000 Share Price $4.84 Est. Cost/Share — Unrealized @ Report Date —
KRYS KRYSTAL BIOTECH INC 0.1%
Value $10.81M Shares 250,000 Share Price $43.24 Est. Cost/Share — Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 0.1%
Value $10.59M Shares 1,500,000 Share Price $7.06 Est. Cost/Share — Unrealized @ Report Date —
SVRA SAVARA INC 0.1%
Value $10.23M Shares 4,825,086 Share Price $2.12 Est. Cost/Share — Unrealized @ Report Date —
— QUOTIENT LTD 0.1%
Value $9.875M Shares 2,500,000 Share Price $3.95 Est. Cost/Share — Unrealized @ Report Date —
— VERASTEM INC 0.1%
Value $9.823M Shares 3,720,930 Share Price $2.64 Est. Cost/Share — Unrealized @ Report Date —
AKBA AKEBIA THERAPEUTICS INC 0.1%
Value $9.475M Shares 1,250,000 Share Price $7.58 Est. Cost/Share — Unrealized @ Report Date —
PACB PACIFIC BIOSCIENCES CALIF IN 0.1%
Value $9.18M Shares 3,000,000 Share Price $3.06 Est. Cost/Share — Unrealized @ Report Date —
RC READY CAP CORP 0.1%
Value $9.154M Shares 1,267,896 Share Price $7.22 Est. Cost/Share — Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.1%
Value $7.369M Shares 625,000 Share Price $11.79 Est. Cost/Share — Unrealized @ Report Date —
DMTKQ DERMTECH INC 0.1%
Value $6.809M Shares 605,255 Share Price $11.25 Est. Cost/Share — Unrealized @ Report Date —
— ADVANCED DISP SVCS INC DEL 0.0%
Value $5.793M Shares 176,610 Share Price $32.80 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.0%
Value $4.821M Shares 6,750,000 Share Price $0.71 Est. Cost/Share — Unrealized @ Report Date —
— OPTINOSE INC 0.0%
Value $3.504M Shares 780,484 Share Price $4.49 Est. Cost/Share — Unrealized @ Report Date —
BEAM BEAM THERAPEUTICS INC 0.0%
Value $3.063M Shares 170,164 Share Price $18.00 Est. Cost/Share — Unrealized @ Report Date —
XRX XEROX HOLDINGS CORP 0.0%
Value $2.462M Shares 130,000 Share Price $18.94 Est. Cost/Share — Unrealized @ Report Date —
— CTRIP COM INTL LTD 0.0%
Value $1.985M Shares 2,000,000 Share Price $0.99 Est. Cost/Share — Unrealized @ Report Date —
— CTRIP COM INTL LTD 0.0%
Value $1.948M Shares 2,000,000 Share Price $0.97 Est. Cost/Share — Unrealized @ Report Date —
— APPLIED GENETIC TECHNOL CORP 0.0%
Value $1.924M Shares 586,497 Share Price $3.28 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.0%
Value $1.578M Shares 7,174,613 Share Price $0.22 Est. Cost/Share — Unrealized @ Report Date —
— INTERCEPT PHARMACEUTICALS IN 0.0%
Value $1.211M Shares 1,500,000 Share Price $0.81 Est. Cost/Share — Unrealized @ Report Date —
GOSS GOSSAMER BIO INC 0.0%
Value $1.015M Shares 100,000 Share Price $10.15 Est. Cost/Share — Unrealized @ Report Date —
RVMD REVOLUTION MEDICINES INC 0.0%
Value $454K Shares 20,733 Share Price $21.90 Est. Cost/Share — Unrealized @ Report Date —
— GOL LINHAS AEREAS INTLG S A 0.0%
Value $367K Shares 85,838 Share Price $4.28 Est. Cost/Share — Unrealized @ Report Date —
— EIGER BIOPHARMACEUTICALS INC 0.0%
Value $341K Shares 50,113 Share Price $6.80 Est. Cost/Share — Unrealized @ Report Date —
— PHASEBIO PHARMACEUTICALS INC 0.0%
Value $280K Shares 84,502 Share Price $3.31 Est. Cost/Share — Unrealized @ Report Date —